82 related articles for article (PubMed ID: 8147183)
1. [What advantages does treatment with highly purified FSH have in infertility?].
Breckwoldt M; Nieschlag E; Runnebaum B; Schneider HP
Zentralbl Gynakol; 1994; 116(1):56-7. PubMed ID: 8147183
[No Abstract] [Full Text] [Related]
2. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
3. Twin pregnancy using recombinant gonadotropins in a woman with hypogonadotropic hypogonadism.
Campo S; Campo V; Lanzone A
Gynecol Endocrinol; 2002 Feb; 16(1):27-32. PubMed ID: 11915578
[TBL] [Abstract][Full Text] [Related]
4. Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women.
White DM; Polson DW; Kiddy D; Sagle P; Watson H; Gilling-Smith C; Hamilton-Fairley D; Franks S
J Clin Endocrinol Metab; 1996 Nov; 81(11):3821-4. PubMed ID: 8923819
[No Abstract] [Full Text] [Related]
5. [Assisted reproduction strategy on polycystic ovarian syndrome].
Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2003 Aug; 38(8):484-6. PubMed ID: 14627036
[No Abstract] [Full Text] [Related]
6. Assessment of ovarian reserve by using the follicle-stimulating hormone isoform distribution pattern to predict the outcome of in vitro fertilization.
Letterie GS; Lee JS; Padmanabhan V
Fertil Steril; 2006 Nov; 86(5):1547-9. PubMed ID: 16999956
[TBL] [Abstract][Full Text] [Related]
7. Letrozole induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone/follicle-stimulating hormone ratio.
Elnashar A; Fouad H; Eldosoky M; Saeid N
Fertil Steril; 2006 Feb; 85(2):511-3. PubMed ID: 16595244
[TBL] [Abstract][Full Text] [Related]
8. In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: description of a novel approach to fertility preservation.
Oktay K; Demirtas E; Son WY; Lostritto K; Chian RC; Tan SL
Fertil Steril; 2008 Jan; 89(1):228.e19-22. PubMed ID: 17517403
[TBL] [Abstract][Full Text] [Related]
9. [From theory to clinical practice: recombinant FSH in daily practice].
Kably Ambe A; Barrón Vallejo J; Góngora Rodríguez A; Carballo Mondragón E; Anta Jaén E
Ginecol Obstet Mex; 1999 Aug; 67():408-13. PubMed ID: 10504796
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
[TBL] [Abstract][Full Text] [Related]
11. Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone.
Matthews CH; Borgato S; Beck-Peccoz P; Adams M; Tone Y; Gambino G; Casagrande S; Tedeschini G; Benedetti A; Chatterjee VK
Nat Genet; 1993 Sep; 5(1):83-6. PubMed ID: 8220432
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques.
Cheon KW; Byun HK; Yang KM; Song IO; Choi KH; Yoo KJ
J Reprod Med; 2004 Sep; 49(9):733-8. PubMed ID: 15493565
[TBL] [Abstract][Full Text] [Related]
13. Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET.
Drakakis P; Loutradis D; Kallianidis K; Liapi A; Milingos S; Makrigiannakis A; Dionyssiou-Asteriou A; Michalas S
Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):77-80. PubMed ID: 15989987
[TBL] [Abstract][Full Text] [Related]
14. [Effect of concentration of circulating luteinizing hormone in late-follicle phase on the outcome of in vitro fertilization for normogonadotrophic women].
Sun H; Hu Y; Wang B; Chen Q; Zhang N; Chen H; Wang J; Xu Z
Zhonghua Nan Ke Xue; 2004 Dec; 10(12):912-5. PubMed ID: 15638021
[TBL] [Abstract][Full Text] [Related]
15. The use of pure follicle stimulating hormone during the luteal phase to increase success of ovulation induction in poor responders: a pilot study.
Trott EA; Chakraborty S; Russell JB
Del Med J; 1998 May; 70(5):249-51. PubMed ID: 9635346
[No Abstract] [Full Text] [Related]
16. Individualized cost-effective conventional ovulation induction treatment in normogonadotrophic anovulatory infertility (WHO group 2).
Eijkemans MJ; Polinder S; Mulders AG; Laven JS; Habbema JD; Fauser BC
Hum Reprod; 2005 Oct; 20(10):2830-7. PubMed ID: 16006473
[TBL] [Abstract][Full Text] [Related]
17. [Chronic low dose follicle stimulating hormone step-up regimen in the treatment of polycystic ovary syndrome related anovulatory infertility with clomiphene resistance].
Chen W; Zhang Y; Dai Q
Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):588-90. PubMed ID: 11372406
[TBL] [Abstract][Full Text] [Related]
18. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
[TBL] [Abstract][Full Text] [Related]
19. [Clinical use of recombinant gonadotropins (FSH, LH, hCG)].
Antoine JM; Loumaye E; Alvarez S; Merviel P; Cornet D; Mandelbaum J; Salat-Baroux J
Contracept Fertil Sex; 1997 Feb; 25(2):141-6. PubMed ID: 9116774
[TBL] [Abstract][Full Text] [Related]
20. Clinical and endocrine effects of ovulation induction with FSH and hCG supplementation in low responders in the midfollicular phase. A pilot study.
Ferrari B; Barusi L; Coppola F
J Reprod Med; 2002 Feb; 47(2):137-43. PubMed ID: 11883353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
